Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. (2019)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-18-2812
PubMed Identifier: 30952632
Publication URI: http://europepmc.org/abstract/MED/30952632
Type: Journal Article/Review
Volume: 79
Parent Publication: Cancer research
Issue: 10
ISSN: 0008-5472